Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Arch Gen Psychiatry. 2012 Oct;69(10):1031–1043. doi: 10.1001/archgenpsychiatry.2011.2062

Table 3.

Persistence of disorders from baseline to Time 1 and from baseline to Time 2, by sexa,b

Disorder Males
Females
OR (95% CI) for Persistence to Time 1, M vs F OR (95% CI) for Persistence to Time 2, M vs F
Disorder Present at Baseline (n) % (SE) Persisting
Disorder Present at Baseline (n) % (SE) Persisting
Time 1 Time 2 Time 1 Time 2
Any Disorderc 335 52.1 (5.8) 48.7 (6.1) 233 54.0 (4.2) 34.9 (4.9)
Any Mood Disorder 163 28.0 (6.1) 18.9 (5.7) 144 30.4 (4.6) 20.9 (4.2)
Any Major Mood Disorder 127 18.8 (5.6) 17.3 (6.1) 124 25.9 (4.7) 19.2 (4.3)
  Maniad 16 --- --- --- --- 8 --- --- --- ---
  Major depression 116 20.0 (6.2) 15.7 (6.3) 118 25.3 (4.7) 17.9 (4.2)
 Hypomaniad 16 --- --- --- --- 2 --- --- --- ---
 Dysthymia 98 1.6 (1.0) 0.0 87 3.8 (2.2) 3.9 (2.2)
Any Anxiety Disorderc 50 6.3 (3.1) 14.8 (9.7) 58 19.3 (6.3) 17.3 (7.1)
 Generalized anxiety disorder 34 18.8 (11.3) 0.0 35 9.4 (5.2) 10.4 (7.0)
 Panic disorderd 3 --- --- --- --- 7 --- --- --- ---
 Post-traumatic stress disorderc 37 5.8 (3.6) 4.0 (2.9) 42 4.5 (3.2) 5.4 (3.7)
Any Disruptive Behavior Disorder 388 36.6 (4.7) 31.1 (4.7) 230 30.7 (4.8) 10.5 (2.4) 3.83 (1.98, 7.43)
Any Substance Use Disordere 517 38.0 (3.8) 34.3 (3.8) 266 30.5 (4.6) 18.2 (2.7) 1.95 (1.09, 3.51) 3.68 (2.10, 6.44)
 Alcohol use disordere 219 30.4 (5.6) 29.3 (5.7) 127 16.2 (3.4) 12.3 (3.3) 2.66 (1.21, 5.85) 3.62 (1.49, 8.77)
 Drug use disordere 482 28.4 (3.7) 23.1 (3.4) 246 22.6 (5.2) 13.6 (2.4) 2.96 (1.59, 5.51)

SE = Standard error; OR = Odds Ratio; CI = Confidence Interval; M = Male; F = Female

a

Rates of persistence and their associated standard errors are weighted to adjust for sampling design and reflect the demographic characteristics of the Cook County Juvenile Temporary Detention Center.

b

Persistence is presented for disorders assessed with impairment criteria, with the exception of hypomania, which has no impairment criteria for diagnosis. We do not present rates of persistence for disorders assessed only for juveniles or adults (Attention-deficit/hyperactivity disorder, conduct disorder, oppositional defiant disorder, or antisocial personality disorder).

c

Assessed at baseline for participants who were interviewed after the DISC-IV post-traumatic stress disorder module became available (n = 541 males and 374 females).

d

Rates of persistence are not presented for disorders with fewer than 20 cases at baseline.

e

Odds ratios describing gender differences in the persistence of substance use disorders are adjusted for number of days incarcerated in the past year.